Landos Biopharma, Inc. (LABP) Social Stream



Landos Biopharma, Inc. (LABP): $4.15

0.10 (-2.35%)

POWR Rating

Component Grades

Momentum

D

Stability

C

Sentiment

Quality

D

Add LABP to Watchlist
Sign Up

Industry: Biotech

Industry

NR

Ranked

#199 of 443

in industry

LANDOS BIOPHARMA INC (LABP) Price Targets From Analysts

Use the tables below to see what analysts covering LANDOS BIOPHARMA INC think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-10-20 6 $50 $15 $32.833 $4.17 687.36%
2021-11-16 6 $50 $15 $30 $4.17 619.42%
2022-01-03 6 $50 $7 $28.666 $4.17 587.43%
2022-03-24 6 $50 $7 $26.166 $4.17 527.48%
2022-04-12 6 $50 $1.4 $21.4 $4.17 413.19%
2022-05-12 6 $50 $0.8 $24.16 $4.17 479.38%
2022-05-13 6 $50 $0.8 $18.2 $4.17 336.45%
2022-08-12 5 $50 $0.8 $17.933 $4.17 330.05%
2022-11-11 3 $2 $0.2 $1.1 $4.17 -73.62%
2023-02-08 3 $2 $0.1 $1.05 $4.17 -74.82%
2023-03-24 2 $2 $0.1 $1.05 $4.17 -74.82%
2023-05-12 1 $10 $10 $10 $4.17 139.81%
2023-05-16 2 $1 $0.1 $0.55 $4.17 -86.81%
2023-11-09 1 $5 $5 $5 $4.17 19.9%

Price Target Last Issued May 12, 2023

The Trend in the Analyst Price Target


Over the past 32 months, LABP's average price target has gone down $23.33.

LABP reports an average of 673.57% for its upside potential over the past 44 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-01-06 3 2 0.1 1.05 0.405 159.26%
2023-02-08 3 2 0.1 1.05 0.385 172.73%
2023-05-12 2 1 0.1 0.55 0.298 84.56%
2023-05-16 2 10 1.0 5.50 2.905 89.33%
2023-05-16 2 1 0.1 0.55 0.290 89.66%

LABP Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
3 0 0 1 0 0 1

The Trend in the Broker Recommendations


LABP's average broker recommendation rating worsened by 1 over the prior 20 months.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • To contextualize these metrics, consider that out of all US stocks, LANDOS BIOPHARMA INC's variance in analysts' estimates is lower than -1921.33% of them.
  • In the context of all US stocks, LANDOS BIOPHARMA INC's upside potential (average analyst target price relative to current price) is greater than 1376.93% of them.
  • LABP has a higher number of analysts covering the stock than 481.96% of Healthcare stocks.
  • LABP has a greater average analyst price target than 885.12% of stocks in the small market cap category.

Stocks similar to LANDOS BIOPHARMA INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are TERN, SNSE, and PHVS.

Is LABP a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!